It has been documented that dual inhibition of monoamine oxidase (MAO) and cholinesterase enzymes, which are complicit in AD’s complex pathophysiology, improve cognitive functions, achieve neuroprotectivity, and subsequently halt disease progression. Here, BCHE is linked to Alzheimer disease.